Adenovirus-derived vectors for prostate cancer gene therapy

DE VRIJ, J., WILLEMSEN, R. A., LINDHOLM, L., HOEBEN, R. C., BANGMA, Ch. H., BARBER, Ch., BEHR, J.-P., BRIGGS, S., CARLISLE, R., CHENG, W.-S., DAUTZENBERG, I. J. C., DE RIDDER, C., DZOJIC, H., ERBACHER, P., ESSAND, M., FISHER, K., FRAZIER, A., GEORGOPOULOS, L. J., JENNINGS, I., KOCHANEK, S., KOPPERS-LALIC, D., KRAAIJ, R., KREPPEL, F., MAGNUSSON, M., MAITLAND, N., NEUBERG, P., NUGENT, R., OGRIS, M., REMY, J.-S., SCAIFE, M., SCHENK, E., SCHOOTEN, E., SEYMOUR, L., SLADE, M., SZYJANOWICZ, P., TOTTERMAN, T., UIL, T. G., ULBRICH, Karel, VAN DER WEEL, L., VAN WEERDEN, W., WAGNER, E., ZUBER, G. Adenovirus-derived vectors for prostate cancer gene therapy. Human Gene Therapy. 2010, 21(7), 795-805. ISSN 1043-0342. E-ISSN 1557-7422. Dostupné z: doi: 10.1089/hum.2009.203